Journal profile · Peripheral Vascular Disease
Gefasschirurgie
ISSN 0948-7034 · eISSN 1434-3932 · Springer Medizin · GERMANY · Bimonthly · Founded 1997
Gefasschirurgie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.3 (journal website); hybrid open access; APC about USD 2,390; median 41 days to acceptance (35 articles, last 24 months); community-reported acceptance: easy; 130 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Gefasschirurgie is published by Springer Medizin and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Peripheral Artery Disease Management, Aortic aneurysm repair treatments and Cardiac, Anesthesia and Surgical Outcomes, together about 29.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Zielsetzung der Zeitschrift Gefässchirurgie informiert über aktuelle Entwicklungen in der vaskulären und endovaskulären Gefaßmedizin. Die Zeitschrift wendet sich an Gefäßchirurginnen und Gefäßchirurgen sowie Sachkundige angrenzender Fachgebiete in Praxis, Klinik und Forschung. Praxisorientierte Übersichtsarbeiten greifen ausgewählte Themen auf und bieten den Lesenden eine Zusammenstellung aktueller Erkenntnisse aus allen Bereichen der Gefäßmedizin. Neben der Vermittlung von relevantem Hintergrundwissen liegt der Schwerpunkt dabei auf der Bewertung wissenschaftlicher Ergebnisse und praktischer Erfahrung. Die Leser*innen erhalten konkrete Handlungsempfehlungen. Frei eingereichte Originalien ermöglichen die Präsentation wichtiger klinischer Studien und dienen dem wissenschaftlichen Austausch. Kasuistiken zeigen interessante Fallbeispiele und ungewöhnliche Krankheits- bzw. Behandlungsverläufe. Beiträge der Rubrik "CME Zertifizierte Fortbildung" bieten gesicherte Ergebnisse wissenschaftlicher Forschung und machen ärztliche Erfahrung für die tägliche Praxis nutzbar. Nach Lektüre der Beiträge können die Lesenden ihr erworbenes Wissen überprüfen und online CME-Punkte erwerben. Die Rubrik orientiert sich an der Weiterbildungsordnung des Fachgebiets. Review All articles of Gefässchirurgie undergo a peer review process. Declaration of Helsinki All manuscripts submitted for publication presenting results from studies on probands or patients must comply with the Declaration of Helsinki. Aims & Scope Gefässchirurgie is an internationally recognized journal dealing with all aspects of vascular medicine including surgery, endovascular therapy, angiology, phlebology and articles to basic reasearch. It provides information on current developments in vascular and endovascular surgery and addresses all specialists and scientists who are particularly interested in issues of vascular medicine. Freely submitted original papers allow the presentation of important clinical studies and serve scientific exchange. Case reports feature interesting cases and aim at optimizing diagnostic and therapeutic strategies. Comprehensive reviews on a specific topical issue focus on providing evidenced based information on diagnostics and therapy. Review articles under the rubric “Continuing Medical Education” present verified results of scientific research and their integration into daily practice. Authors have the possibility to submit and publish their manuscript in English. Review All article
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Axel Larena-AvellanedaPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named Germany 52, Austria 7, Switzerland 4, United States 3, United Kingdom 2 (72 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Peripheral Artery Disease ManagementMedicine11.8%
- Aortic aneurysm repair treatmentsMedicine10.3%
- Cardiac, Anesthesia and Surgical OutcomesMedicine7.3%
- Vascular Procedures and ComplicationsMedicine7%
- Cerebrovascular and Carotid Artery DiseasesMedicine6.3%
- Venous Thromboembolism Diagnosis and ManagementMedicine5.4%
- Medical Practices and RehabilitationHealth Professions5.3%
- Aortic Disease and Treatment ApproachesMedicine5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.3Publisher website ·
- CiteScore 2026-06
- 0.5LetPub ·
- SJR 2026-06
- 0.13LetPub ·
- SNIP 2026-06
- 0.17LetPub ·
- h-index
- 13LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 108OpenAlex ·
- 2-year mean citedness
- 0.19OpenAlex ·
- Self-citation rate
- 33.3%LetPub ·
- Share of gold OA articles
- 23.61%LetPub ·
Volume
- Articles per year
- 85LetPub ·
- Downloads per year (publisher) 2025
- 206,800Publisher website ·
Articles by year OpenAlex count · 2,866 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 92 | 32 | 2 |
| 2025 | 130 | 55 | 22 |
| 2024 | 98 | 34 | 37 |
| 2023 | 102 | 50 | 128 |
| 2022 | 107 | 42 | 98 |
| 2021 | 115 | 41 | 99 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
41 daysMedian, submission to acceptance · P25–P75 19 days – 63 days
- Acceptance to online
- median 28 days (79 articles)
- Submission to online
- median 72 days
- Sample
- 35 articles with submission and acceptance dates (252 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,390 / EUR 3,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteData availability, Open access
- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Gefässchirurgie, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Medizin
- Country or region
- GERMANY
- Frequency
- Bimonthly
- Founded
- 1997
- ISSN
- 0948-7034
- Electronic ISSN
- 1434-3932
- Latest issue on the website
- Volume 31, Issue 6 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Gefasschirurgie
What CAS zone is Gefasschirurgie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Gefasschirurgie is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Gefasschirurgie?
The journal's website gives an impact factor of 0.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 0.5, h-index 22.
How long does peer review take at Gefasschirurgie?
Based on the dates recorded on 35 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 41 days (interquartile range 19–63 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Gefasschirurgie based?
Of the 72 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Germany (52), Austria (7) and Switzerland (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Gefasschirurgie?
According to LetPub and DOAJ records, Gefasschirurgie is indexed in ESCI and Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Gefasschirurgie open access, and what is the APC?
Gefasschirurgie is a hybrid journal. For open-access publication: APC about USD 2,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .